Secukinumab Therapeutic Cheat Sheet
Secukinumab is a recombinant human monoclonal immunoglobulin IgG1κ antibody that selectively targets interleukin-17A (IL-17A), a key effector cytokine in the Th17 pathway implicated in the pathogenesis of psoriasis. With its high target specificity, rapid onset, sustained efficacy, and favorable safety profile, secukinumab has become a mainstay in the treatment of psoriasis and other inflammatory …
Secukinumab is a recombinant human monoclonal immunoglobulin IgG1κ antibody that selectively targets interleukin-17A (IL-17A), a key effector cytokine in the Th17 pathway implicated in the pathogenesis of psoriasis. With its high target specificity, rapid onset, sustained efficacy, and favorable safety profile, secukinumab has become a mainstay in the treatment of psoriasis and other inflammatory … 
A resurgence in the use of isotretinoin is one of the developments changing the way Dr. Neal Bhatia treats acne. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Bhatia, a dermatologist in San Diego. Watch as Dr. Bhatia shares some new developments in the management of patients on isotretinoin. Hear the benefits of a newly marketed triple combination cream. … 
A model and influencer is making news for using her sister’s breast milk as part of her skincare routine. According to an article in People magazine, Quenlin Blackwell uses the breast milk for baths and face masks. Dermatologist Dr. Naana Boakye said breast milk has shown potential for soothing inflammatory skin conditions as well as moisturizing and strengthening the skin barrier. Dr. Boakye re … 
While the importance of wearing sunscreen is often emphasized, rarely do we stop to consider how sunscreen works and why it is effective. A thorough understanding of these details is essential for dermatologists and trainees alike to feel confident navigating conversations with patients about sunscreen formulations, efficacy, and safety. At the inaugural Lab to Label Conference, Dr. Candrice Heath … 
The psoriasis research pipeline is rich with new medications as well as new ways to use existing therapies, according to Dr. Anthony Fernandez, director of medical and inpatient dermatology at the Cleveland Clinic. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Fernandez, who outlined three therapeutic areas he’s most excited about in the treatment of p … 